drugset / Trial / NCT06810882

Intravenous Versus Perineural Ondansetron for Laparoscopic Sleeve Gastrectomy

NCT06810882

Recruiting 482 enrolled Tanta University
RandomizedParallel-groupDouble-blindPrevention

Summary

This prospective randomized non-inferiority study will be conducted to compare the analgesic anti-emetic effects of intravenous ondansetron versus perineural ondansetron in patients undergoing laparoscopic sleeve gastrectomy.

Timeline

Start
2025-02-16
Primary completion
2027-02-16
Completion
2027-02-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ondansetron Other / unclassified 4 mg Other
Comparator Ondansetron Other / unclassified 4 mg Intravenous

Indications

No indication recorded.